Women on hormone therapy regain emotion responseOctober 17, 2006OHSU study finds women on extrogen recoup loss of response to negative emotional events PORTLAND, Ore.-Older women on hormone therapy are more sensitive to negative events, confirming speculation that age-related estrogen loss affects the brain's ability to process emotion, an Oregon Health & Science University study shows. But that sensitivity to negative emotional events, such as viewing a photograph of a dead person, doesn't necessarily mean women taking estrogen remember those events any better. In the study by researchers in the Cognition & Aging Laboratory at the OHSU School of Medicine's Department of Behavioral Neuroscience, hormone therapy in women appears to reverse the age-related loss of arousal to negative emotional events experienced by the elderly. It also points to specific changes in the brain's arousal system, in the regions that process emotion, and intensification of negative emotions. The results were presented today at Neuroscience 2006, the Society for Neuroscience's 36th annual meeting at the Georgia World Congress Center in Atlanta. Scientists have suspected a link between sex hormones and emotion. Strengthening this theory is the fact that brain regions tuned for processing emotion and storing emotional memory-the amygdala and hippocampus-also respond to sex hormones and contain hormone receptors. Thus, changes in "emotional enhancement" people experience as they age, including a reduction in the ability to remember negative events, may be modified by age-related loss of sex hormones or hormone therapy. In the OHSU study, researchers compared the emotional responsiveness of 45 healthy older, post-menopausal women ages 65 to 85 who had used hormone therapy an average of more than 20 years, to that of 26 women not on hormone therapy. Their performance also was compared to that of young women ages 24 to 40, also on no hormone therapy. The groups participated in two studies about emotion, including one in which they viewed scenes that had positive, neutral or negative emotional content A negative scene might contain a dead person, while a positive scene might contain puppies. The women then rated the scenes for valence, or the positive or negative nature of the scene, and arousal, or the intensity of the emotion. The women's memory for the scenes was then tested one to two weeks later. While younger and older women, regardless of their hormone status, had similar valence ratings and similar patterns for memory, the groups differed in their ratings of arousal for the scenes. Women on hormone therapy rated negative scenes as more arousing than positive scenes, and just the opposite was found in the women without hormone therapy. Similar results were found for responses to a story that contained negative content. Women on hormone therapy showed more arousal for the negative section of the story, and this increase in arousal carried over to the neutral ending. The type of hormone therapy, such as estrogen alone or in combination with progesterone, did not affect results. Despite increased arousal for negative scenes and events, hormone therapy did not impact memory. Heightened arousal did not translate into better memory for negative events as has been found in younger people. Therefore, in aging, the scientists suggest, the arousal system is modified and can't direct memory consolidation as it does in the young. Heightened arousal to negative material among older women using hormone therapy is intriguing because the amygdala responds to emotional material and is also a site for estrogen activity, the researchers explained. One possible explanation for this is estrogen increases and sustains amygdala reactivity to negative emotional material in older women, but the brain system critical for storage of information, the hippocampus, does not respond to the increased signal from the amygdala. Current studies are using neuroimaging methods, such as magnetic resonance imaging (MRI), to study brain activity in older men and women to investigate how hormone loss or hormone therapies change the brain's processing and memory for emotional events. Oregon Health & Science University |
|||||||||||||||||||||
| Related Hormone Therapy Current Events and Hormone Therapy News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone. Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. Hormone mix could cut breast cancer risk and treat symptoms of menopause The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk. Breast tenderness during hormone replacement therapy linked to elevated cancer risk Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study. Women with breast cancer have low vitamin D levels Women with breast cancer should be given high doses of vitamin D because a majority of them are likely to have low levels of vitamin D, which could contribute to decreased bone mass and greater risk of fractures, according to scientists at the University of Rochester Medical Center. Researchers believe hormone therapy should not be stopped prior to mammograms Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. Prostate cancer patients on hormone therapy at increased risk for various heart diseases New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems. Some choices of therapy appear, however, to be less risky than others. Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than four-fold increased risk of a more aggressive, difficult-to-treat type of cancer in the breast opposite, or contralateral, to the initial tumor. More Hormone Therapy Current Events and Hormone Therapy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||